Exquando uses cookies on this website to provide you with the best possible browsing experience. If you would like more information on the use of cookies, you can consult our Cookies policy. By continuing to browse or use our site without having accepted or refused cookies, only cookies essential for browsing our website are used. You can also choose to accept all cookies or customize their use. You can change your preferences at any time via the icon cookie
Configurez les cookies / Cookies configuration / Cookies configuratie

(FR) Les cookies fonctionnels sont essentiels pour le fonctionnement du site internet et ne peuvent être désactivés. Pour améliorer votre expérience, d'autres cookies sont utilisés. Vous pouvez choisir de les désactiver. Ils restent modifiables à tout moment via cette fenêtre.

(EN) Functional cookies are essential for the operation of the website and cannot be deactivated. To improve your experience, other cookies are used. You can choose to turn them off. They can be modified at any time via this window.

(NL) Functionele cookies zijn essentieel voor de werking van de website en kunnen niet worden gedeactiveerd. Om uw ervaring te verbeteren, worden andere cookies gebruikt. U kunt ervoor kiezen om ze uit te schakelen. Ze kunnen op elk moment worden gewijzigd via dit venster.

Cookies fonctionnels / Functional cookies / Functionele cookies
Cookies d'analyse et de marketing / Analysis and marketing cookies / Analyse- en marketingcookies
En savoir plus sur la politique d'usage des cookies / Learn more about the use of cookies policy / Meer informatie over het gebruik van het cookiebeleid
Sauvegarder / Save / Sparen

Exquando facilitates the reception of a new GSK production site with Aproplan

Under its partnership with Aproplan, Exquando delivered a first installation to GSK Vaccines at a construction site of a new vaccines production unit in Wavre. The use of Aproplan for the reception of the new unit should reduce the workload by two.

Project managers at GSK were looking for a way to optimise the reception process of the new production unit. Until now, the annotations resuming the defect points identified during site visits were always made manually on hard copies of construction plans; the annotations were then transferred on an Excel sheet and punch lists were produced and sent to the concerned contracting partners.

With the set-up of Aproplan, notes on defect points can be encoded directly on site with an iPad containing the latest construction layouts. The system then immediately generates and sends punch lists to contracting partners.

Exquando facilitated the implementation of Aproplan at GSK by developing new processes, by ensuring the system parameterization and by creating new reports compliant with the pharmaceutical sector requirements. The Exquando team also offers training and support to users. As a result, the GSK engineers have immediately and easily adopted the new system.

LinkedIn Facebook